ClinicalTrials.Veeva

Menu
A

Alberta Health Services | Alberta Children's Hospital, Department of Neurosciences

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Macitentan
Dexamethasone
Lebrikizumab
TAK-659
CyBorD
Acetylsalicyclic acid
S42909
Oseltamivir
Tadalafil
MHAA4549A

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 19 total trials

A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

The purpose of this study is to evaluate the efficacy and safety of daratumumab plus cyclophosphamide, bortezomib and dexamethasone (CyBorD) compared...

Active, not recruiting
Amyloidosis
Drug: Daratumumab
Drug: Cyclophosphamide

Trial sponsors

Actelion Pharmaceuticals logo
Roche logo
U
C
Exact Sciences Corporation logo
Genentech logo
I
Janssen (J&J Innovative Medicine) logo
L
Population Health Research Institute (PHRI) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems